Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.898 EUR | -0.72% | +3.46% | -12.90% |
Apr. 22 | Pharming Group to Buy Back EUR123 Million of Bonds due 2025 | MT |
Apr. 18 | Pharming Group to Issue EUR100 Million Convertible Bonds, Repurchase EUR125 Million Bonds | MT |
Business Summary
Pharming Group N.V. serves patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia/Pacific.
Number of employees: 382
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Recombinant Human C1 Esterase Inhibitor
100.0
%
| 196 | 100.0 % | 227 | 100.0 % | +15.98% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
97.5
%
| 190 | 97.3 % | 221 | 97.5 % | +16.17% |
Europe and Rest of World
2.5
%
| - | - | 6 | 2.5 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sijmen de Vries
CEO | Chief Executive Officer | 65 | 08-10-12 |
Jeroen Wakkerman
DFI | Director of Finance/CFO | 55 | 20-11-15 |
Anurag Relan
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Mireille Sanders
COO | Chief Operating Officer | 56 | 19-04-30 |
Compliance Officer | 60 | 20-03-31 | |
Michael Levitan
IRC | Investor Relations Contact | 66 | - |
Stephen Toor
PRN | Corporate Officer/Principal | 52 | 20-12-14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Pykett
BRD | Director/Board Member | 60 | 20-12-10 |
Leonard Kruimer
BRD | Director/Board Member | 66 | 21-05-18 |
Sijmen de Vries
CEO | Chief Executive Officer | 65 | 08-10-12 |
Steven Baert
BRD | Director/Board Member | 50 | 21-03-31 |
Deborah Jorn
BRD | Director/Board Member | 66 | 19-05-21 |
Barbara Yanni
BRD | Director/Board Member | 69 | 20-12-10 |
Director/Board Member | 58 | 21-05-18 | |
Richard Peters
CHM | Chairman | 61 | 23-09-24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 671,073,243 | 655,383,865 ( 97.66 %) | 0 | 97.66 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.27% | 651M | |
+25.61% | 660B | |
+25.87% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+7.09% | 219B | |
-9.12% | 196B | |
+5.01% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- PHARM Stock
- Company Pharming Group N.V.